{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:09:11Z","timestamp":1780582151522,"version":"3.54.1"},"reference-count":42,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["21K19751"],"award-info":[{"award-number":["21K19751"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["22H03048"],"award-info":[{"award-number":["22H03048"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["23K24309"],"award-info":[{"award-number":["23K24309"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["24K13798"],"award-info":[{"award-number":["24K13798"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2026,1,22]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>BRCA2<\/jats:italic>\n                      c.7847C&gt;T (p.Ser2616Phe) variant is specific to the Japanese population and has long remained a variant of uncertain significance. Because\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      genetic testing serves as a companion diagnostic for poly (ADP-ribose) polymerase inhibitor therapy in Japan, unresolved classification has limited access to targeted treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a nationwide study using the national Hereditary Breast and Ovarian Cancer registry. Pathogenicity was assessed through quantitative cosegregation analysis, a systematic review of functional and clinical evidence and evaluation of variant frequency in population databases. Evidence was integrated using the ClinGen ENIGMA\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      Variant Curation Expert Panel framework.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 44 carriers from 35 distinct Japanese families. Quantitative cosegregation analysis yielded a combined likelihood ratio of approximately 60, satisfying the PP1_Strong criterion. This was supported by robust evidence from multiple functional studies, including Mixed-All-Nominated-in-One-BRCA, homology-directed repair and saturation genome editing assays (PS3) and a reported case of Fanconi anaemia (PM3_Moderate). This variant is rare, with an allele frequency of 6.20\u00d710\n                      <jats:sup>\u20137<\/jats:sup>\n                      in gnomAD and 1.06\u00d710\n                      <jats:sup>\u20134<\/jats:sup>\n                      in ToMMo 61KJPN (PM2_Supporting). Although the BayesDel noAF score met the benign criterion (BP4), other in silico tools indicated deleterious effects. In total, the accumulated evidence reached 10 points, corresponding to an estimated odds of pathogenicity of 895:1, exceeding the \u2018Pathogenic\u2019 threshold.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      By integrating newly collected genetic data with functional and clinical evidence, we provide robust support for reclassifying the\n                      <jats:italic>BRCA2<\/jats:italic>\n                      c.7847C&gt;T (p.Ser2616Phe) variant as \u2018Pathogenic\u2019. This reclassification is crucial for ensuring that eligible Japanese patients gain access to appropriate targeted therapies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmg-2025-111305","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:20:23Z","timestamp":1773940823000},"page":"393-404","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive evidence for the pathogenicity of the\n                    <i>BRCA2<\/i>\n                    c.7847C&gt;T (p.Ser2616Phe) variant specific to the Japanese population"],"prefix":"10.1136","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-2759","authenticated-orcid":false,"given":"Kazuki","family":"Yamazawa","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, NHO Tokyo Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Kuga","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Hinoi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Niitsu","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Minatogawa","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Wakayama Medical University Hospital, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Okawa","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, St Luke\u2019s International Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, St Luke\u2019s International Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Center for Clinical Genetics and Genomic Medicine, Showa Medical University Fujigaoka Hospital, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Enokido","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Akimaru","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan"},{"name":"Department of Breast Surgery, Osaka Red Cross Hospital, Osaka, Japan"},{"name":"Department of Breast and Endocrine Surgery, Osaka Breast Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masae","family":"Torii","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Tsuyuki","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Osaka Red Cross Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikage","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Osaka Breast Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazuko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Tanoshima","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Yokohama City University Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumi","family":"Harada-Shoji","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Tohoku University School of Medicine, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Taruno","sequence":"additional","affiliation":[{"name":"Division of Breast Surgical Oncology, Showa Medical University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Juntendo University Graduate School of Medicine, Tokyo, Japan"},{"name":"Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Ethics Support Unit\/Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Kindai University Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kokichi","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine, Sasaki Foundation, Kyoundo Hospital, Tokyo, Japan"},{"name":"Department of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Tanakaya","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Iwakuni Clinical Center, Iwakuni, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, NHO Tokyo Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, NHO Tokyo Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, NHO Tokyo Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Makabe","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, NHO Tokyo Medical Center, Tokyo, Japan"},{"name":"Department of Obstetrics and Gynecology, NHO Tokyo Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Kosaki","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, NHO Tokyo Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026060310100817000_63.6.393.1","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1111\/cas.15799","article-title":"The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition","volume":"114","author":"Yamazawa","year":"2023","journal-title":"Cancer Sci"},{"key":"2026060310100817000_63.6.393.2","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1111\/cas.70040","article-title":"The Time Lag Associated With the Reclassification of Germline BRCA Variants\u2019 Pathogenicity Is Critical for Cancer Patients","volume":"116","author":"Hayashi","year":"2025","journal-title":"Cancer Sci"},{"key":"2026060310100817000_63.6.393.3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s10038-023-01194-6","article-title":"Functional evaluation of BRCA1\/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model","volume":"68","author":"Guo","year":"2023","journal-title":"J Hum Genet"},{"key":"2026060310100817000_63.6.393.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2024.02.002"},{"key":"2026060310100817000_63.6.393.5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41586-024-08388-8","article-title":"Functional evaluation and clinical classification of BRCA2 variants","volume":"638","author":"Huang","year":"2025","journal-title":"Nature"},{"key":"2026060310100817000_63.6.393.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08318-0"},{"key":"2026060310100817000_63.6.393.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2024.07.013"},{"key":"2026060310100817000_63.6.393.8","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2026060310100817000_63.6.393.9","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-017-0355-1"},{"key":"2026060310100817000_63.6.393.10","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2022.33.e46","article-title":"Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy","volume":"33","author":"Sekine","year":"2022","journal-title":"J Gynecol Oncol"},{"key":"2026060310100817000_63.6.393.11","doi-asserted-by":"publisher","DOI":"10.1038\/S41436-020-0920-4"},{"key":"2026060310100817000_63.6.393.12","doi-asserted-by":"crossref","unstructured":"Moghadasi S , Monajemi R , Braspenning ME . A comprehensive and accessible model for co-segregation analysis in BRCA1, BRCA2, and PALB2 variant classification. bioRxiv 2024. doi:10.1101\/2024.09.23.614309","DOI":"10.1101\/2024.09.23.614309"},{"key":"2026060310100817000_63.6.393.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07050-7"},{"key":"2026060310100817000_63.6.393.14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad978"},{"key":"2026060310100817000_63.6.393.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0322-9"},{"key":"2026060310100817000_63.6.393.16","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00871-4"},{"key":"2026060310100817000_63.6.393.17","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14060"},{"key":"2026060310100817000_63.6.393.18","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"2026060310100817000_63.6.393.19","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23158"},{"key":"2026060310100817000_63.6.393.20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1016"},{"key":"2026060310100817000_63.6.393.21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab266"},{"key":"2026060310100817000_63.6.393.22","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248"},{"key":"2026060310100817000_63.6.393.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.08.016"},{"key":"2026060310100817000_63.6.393.24","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.123"},{"key":"2026060310100817000_63.6.393.25","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.210"},{"key":"2026060310100817000_63.6.393.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16141-8","article-title":"High-throughput functional evaluation of BRCA2 variants of unknown significance","volume":"11","author":"Ikegami","year":"2020","journal-title":"Nat Commun"},{"key":"2026060310100817000_63.6.393.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2017.12.013 Helena"},{"key":"2026060310100817000_63.6.393.28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.207241"},{"key":"2026060310100817000_63.6.393.29","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24088"},{"key":"2026060310100817000_63.6.393.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06581-8","article-title":"Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls","volume":"9","author":"Momozawa","year":"2018","journal-title":"Nat Commun"},{"key":"2026060310100817000_63.6.393.31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz124"},{"key":"2026060310100817000_63.6.393.32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103033","article-title":"Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes","volume":"60","author":"Mizukami","year":"2020","journal-title":"EBioMedicine"},{"key":"2026060310100817000_63.6.393.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211807"},{"key":"2026060310100817000_63.6.393.34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","article-title":"Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants","volume":"8","author":"Momozawa","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026060310100817000_63.6.393.35","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32619"},{"key":"2026060310100817000_63.6.393.36","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.7150\/thno.56539","article-title":"Mutational spectrum and precision oncology for biliary tract carcinoma","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"2026060310100817000_63.6.393.37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J Hepatol"},{"key":"2026060310100817000_63.6.393.38","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2026060310100817000_63.6.393.39","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2012-101037"},{"key":"2026060310100817000_63.6.393.40","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2017-104560"},{"key":"2026060310100817000_63.6.393.41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2568"},{"key":"2026060310100817000_63.6.393.42","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/cas.70158","article-title":"Proposal for a Germline Expert Panel to Improve Variant Reclassification in Japan","volume":"116","author":"Yamazawa","year":"2025","journal-title":"Cancer Sci"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2025-111305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:59:32Z","timestamp":1780581572000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2025-111305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,25]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jmg-2025-111305"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2025-111305","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}